Biocryst stock news
WebSep 5, 2024 · RESEARCH TRIANGLE PARK, N.C., Sept. 05, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) today announced final results from its Phase 2 APeX-1 clinical trial in hereditary ... WebApr 14, 2024 · In other BioCryst Pharmaceuticals news, CEO Jon P. Stonehouse sold 100,000 shares of the company’s stock in a transaction that occurred on Wednesday, …
Biocryst stock news
Did you know?
WebApr 6, 2024 · A high-level overview of BioCryst Pharmaceuticals, Inc. (BCRX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and … WebApr 11, 2024 · BioCryst's ORLADEYO is off to a great, great start in HAE, BCRX withdrew their $200mn offering and a few months later, Royalty Pharma and OMERS Capital Market together purchased $350mn of ...
WebApr 6, 2024 · BioCryst Pharmaceuticals, Inc. (BioCryst) is a commercial-stage biotechnology company that discovers small-molecule medicines. The Company focus on oral treatments for rare diseases in which unmet medical needs exist and an enzyme plays the key role in the biological pathway of the disease. ORLADEYO (berotralstat) is an … WebNov 1, 2024 · Mirae Asset Global Investments Co. Ltd. Makes New Investment in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Defense World 10/25/2024
WebDiscover historical prices for BCRX stock on Yahoo Finance. View daily, weekly or monthly format back to when BioCryst Pharmaceuticals, Inc. stock was issued. WebFeb 23, 2024 · BioCryst (BCRX) delivered earnings and revenue surprises of -29.03% and 2.11%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
WebDec 15, 2024 · RESEARCH TRIANGLE PARK, N.C., Dec. 15, 2024 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that, based on new competitive data recently presented at the American ...
WebBioCryst Pharmaceuticals, Inc. is an American pharmaceutical company headquartered in Durham, North Carolina. The company is a late stage biotech company that focuses on oral drugs for rare and serious diseases. ... BioCryst became a public company when it completed an initial public offering by listing its shares on the NASDAQ stock exchange ... dating sites with highest success rateWebMay 4, 2024 · On May 5, BioCryst Pharmaceuticals will report earnings from the Q1. 12 analysts predict losses of $0.363 per share compared to losses of $0.360 per share in the same quarter of the previous year ... bj\u0027s restaurant \u0026 brewhouse allentown paWebApr 6, 2024 · Financial Performance. In 2024, BCRX's revenue was $270.83 million, an increase of 72.31% compared to the previous year's $157.17 million. Losses were … bj\u0027s restaurant rewards programWebApr 18, 2024 · Barclays prognosticator Gena Wang didn't exactly get BioCryst's week off to an encouraging start. Monday morning, she downgraded her recommendation on the … dating sites with no ageWebMar 24, 2024 · BioCryst Pharmaceuticals Inc Stock Price History. BioCryst Pharmaceuticals Inc’s price is currently down 3.95% so far this month. During the month of March, BioCryst Pharmaceuticals Inc’s stock price has reached a high of $8.99 and a low of $7.82. ... Lastly, news and media coverage as well as recent press reports about the … bj\u0027s restaurant \u0026 brewhouse beavercreek ohWebMar 31, 2024 · BioCryst Pharmaceuticals, Inc. Common Stock (BCRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. dating sites with incognito modeWebApr 8, 2024 · RBC Capital analyst Brian Abrahams maintained a Hold rating on BioCryst ( BCRX – Research Report) on April 6 and set a price target of $9.00. The company’s shares closed last Thursday at $8.68 ... dating sites with more men than women